Gynecology ICD-9 to ICD-10 Code Mapper

Total Page:16

File Type:pdf, Size:1020Kb

Gynecology ICD-9 to ICD-10 Code Mapper 2011 GynecologyGynecology ICD-9-CMICD-9-CM to to ICD-10-CM ICD-10-CM Code Code Mapper Mapper 800-334-5724 800-334-5724 www.contexomedia.com www.contexomedia.com 2011 ICD-9-CM ICD-10-CM ICD-9-CM ICD-10-CM 041.02 Streptococcus group B B95.1 Streptococcus, group B, as the 174.6 Malignant neoplasm of C50.611 Malignant neoplasm of axillary tail infection in conditions cause of diseases classified axillary tail of female breast of right female breast classified elsewhere and of elsewhere C50.612 Malignant neoplasm of axillary tail unspecified site of left female breast C50.619 Malignant neoplasm of axillary tail 054.10 Genital herpes, unspecified A60.00 Herpesviral infection of urogenital of unspecified female breast system, unspecified A60.9 Anogenital herpesviral infection, 174.8 Malignant neoplasm of other C50.811 Malignant neoplasm of overlapping unspecified specified sites of female sites of right female breast breast C50.812 Malignant neoplasm of overlapping 054.11 Herpetic vulvovaginitis A60.04 Herpesviral vulvovaginitis sites of left female breast C50.819 Malignant neoplasm of overlapping 054.12 Herpetic ulceration of vulva A60.04 Herpesviral vulvovaginitis sites of unspecified female breast 078.11 Condyloma acuminatum A63.0 Anogenital (venereal) warts 174.9 Malignant neoplasm of breast C50.911 Malignant neoplasm of unspecified (female), unspecified site site of right female breast 091.0 Genital syphilis (primary) A51.0 Primary genital syphilis C50.912 Malignant neoplasm of unspecified site of left female breast 098.0 Gonococcal infection, acute, A54.00 Gonococcal infection of lower C50.919 Malignant neoplasm of unspecified of lower genitourinary tract genitourinary tract, unspecified site of unspecified female breast A54.02 Gonococcal vulvovaginitis, unspecified 180.0 Malignant neoplasm of C53.0 Malignant neoplasm of endocervix A54.09 Other gonococcal infection of lower endocervix genitourinary tract A54.1 Gonococcal infection of lower 180.1 Malignant neoplasm of C53.1 Malignant neoplasm of exocervix genitourinary tract with periurethral exocervix and accessory gland abscess 180.8 Malignant neoplasm of other C53.8 Malignant neoplasm of overlapping 099.53 Other venereal diseases due A56.00 Chlamydial infection of lower specified sites of cervix sites of cervix uteri to Chlamydia trachomatis, genitourinary tract, unspecified lower genitourinary sites A56.01 Chlamydial cystitis and urethritis 180.9 Malignant neoplasm of cervix C53.9 Malignant neoplasm of cervix uteri, A56.02 Chlamydial vulvovaginitis uteri, unspecified site unspecified A56.09 Other chlamydial infection of lower genitourinary tract 182.0 Malignant neoplasm of corpus C54.1 Malignant neoplasm of endometrium uteri, except isthmus C54.2 Malignant neoplasm of myometrium 099.54 Other venereal diseases due A56.11 Chlamydial female pelvic C54.3 Malignant neoplasm of fundus uteri to Chlamydia trachomatis, inflammatory disease C54.9 Malignant neoplasm of corpus uteri, other genitourinary sites A56.19 Other chlamydial genitourinary unspecified infection 182.1 Malignant neoplasm of C54.0 Malignant neoplasm of isthmus uteri 112.1 Candidiasis of vulva and B37.3 Candidiasis of vulva and vagina isthmus vagina 182.8 Malignant neoplasm of other C54.8 Malignant neoplasm of overlapping 174.0 Malignant neoplasm of nipple C50.011 Malignant neoplasm of nipple and specified sites of body of sites of corpus uteri and areola of female breast areola, right female breast uterus C50.012 Malignant neoplasm of nipple and areola, left female breast 183.0 Malignant neoplasm of ovary C56.1 Malignant neoplasm of right ovary C50.019 Malignant neoplasm of nipple and C56.2 Malignant neoplasm of left ovary areola, unspecified female breast C56.9 Malignant neoplasm of unspecified ovary 174.1 Malignant neoplasm of central C50.111 Malignant neoplasm of central portion of female breast portion of right female breast 218.0 Submucous leiomyoma of D25.0 Submucous leiomyoma of uterus C50.112 Malignant neoplasm of central uterus portion of left female breast C50.119 Malignant neoplasm of central 218.1 Intramural leiomyoma of D25.1 Intramural leiomyoma of uterus portion of unspecified female breast uterus 174.2 Malignant neoplasm of upper- C50.211 Malignant neoplasm of upper-inner 218.2 Subserous leiomyoma of D25.2 Subserosal leiomyoma of uterus inner quadrant of female quadrant of right female breast uterus breast C50.212 Malignant neoplasm of upper-inner quadrant of left female breast 218.9 Leiomyoma of uterus, D25.9 Leiomyoma of uterus, unspecified C50.219 Malignant neoplasm of upper-inner unspecified quadrant of unspecified female breast 174.3 Malignant neoplasm of lower- C50.311 Malignant neoplasm of lower-inner inner quadrant of female quadrant of right female breast breast C50.312 Malignant neoplasm of lower-inner quadrant of left female breast C50.319 Malignant neoplasm of lower-inner quadrant of unspecified female breast 174.4 Malignant neoplasm of upper- C50.411 Malignant neoplasm of upper-outer outer quadrant of female quadrant of right female breast breast C50.412 Malignant neoplasm of upper-outer quadrant of left female breast C50.419 Malignant neoplasm of upper-outer quadrant of unspecified female breast 174.5 Malignant neoplasm of lower- C50.511 Malignant neoplasm of lower-outer outer quadrant of female quadrant of right female breast breast C50.512 Malignant neoplasm of lower-outer quadrant of left female breast C50.519 Malignant neoplasm of lower-outer quadrant of unspecified female breast © 20112010 Contexo Media 1 ICD-9-CM ICD-10-CM ICD-9-CM ICD-10-CM 233.0 Carcinoma in situ of breast D05.00 Lobular carcinoma in situ of 610.1 Diffuse cystic mastopathy N60.11 Diffuse cystic mastopathy of right unspecified breast breast D05.01 Lobular carcinoma in situ of right N60.12 Diffuse cystic mastopathy of left breast breast D05.02 Lobular carcinoma in situ of left N60.19 Diffuse cystic mastopathy of breast unspecified breast D05.09 Lobular carcinoma in situ of unspecified breast 610.2 Fibroadenosis of breast N60.21 Fibroadenosis of right breast D05.10 Intraductal carcinoma in situ of N60.22 Fibroadenosis of left breast unspecified breast N60.29 Fibroadenosis of unspecified breast D05.11 Intraductal carcinoma in situ of right breast 610.3 Fibrosclerosis of breast N60.31 Fibrosclerosis of right breast D05.12 Intraductal carcinoma in situ of left N60.32 Fibrosclerosis of left breast breast N60.39 Fibrosclerosis of unspecified breast D05.19 Intraductal carcinoma in situ of unspecified breast 610.4 Mammary duct ectasia N60.41 Mammary duct ectasia of right D05.71 Other carcinoma in situ of right breast breast N60.42 Mammary duct ectasia of left breast D05.72 Other carcinoma in situ of left N60.49 Mammary duct ectasia of breast unspecified breast D05.79 Other carcinoma in situ of unspecified breast 610.9 Benign mammary dysplasia, N60.91 Unspecified benign mammary D05.80 Other specified type of carcinoma in unspecified dysplasia of right breast situ of unspecified breast N60.92 Unspecified benign mammary D05.81 Other specified type of carcinoma in dysplasia of left breast situ of right breast N60.99 Unspecified benign mammary D05.82 Other specified type of carcinoma in dysplasia of unspecified breast situ of left breast D05.90 Unspecified type of carcinoma in 611.0 Inflammatory disease of N61 Inflammatory disorders of breast situ of unspecified breast breast D05.91 Unspecified type of carcinoma in situ of right breast 611.1 Hypertrophy of breast N62 Hypertrophy of breast D05.92 Unspecified type of carcinoma in situ of left breast 611.6 Galactorrhea not associated N64.3 Galactorrhea not associated with D05.99 Unspecified carcinoma in situ of with childbirth childbirth unspecified breast 611.71 Mastodynia N64.4 Mastodynia 233.1 Carcinoma in situ of cervix D06.0 Carcinoma in situ of endocervix uteri D06.1 Carcinoma in situ of exocervix 611.72 Lump or mass in breast N63 Unspecified lump in breast D06.7 Carcinoma in situ of other parts of cervix 611.79 Other signs and symptoms in N64.51 Induration of breast D06.9 Carcinoma in situ of cervix, breast N64.52 Nipple discharge unspecified N64.53 Retraction of nipple N64.59 Other signs and symptoms in breast 233.2 Carcinoma in situ of other and D07.0 Carcinoma in situ of endometrium unspecified parts of uterus 611.82 Hypoplasia of breast N64.82 Hypoplasia of breast 233.31 Carcinoma in situ, vagina D07.2 Carcinoma in situ of vagina 614.0 Acute salpingitis and N70.01 Acute salpingitis oophoritis N70.02 Acute oophoritis 233.32 Carcinoma in situ, vulva D07.1 Carcinoma in situ of vulva N70.03 Acute salpingitis and oophoritis 255.2 Adrenogenital disorders E25.0 Congenital adrenogenital disorders 614.1 Chronic salpingitis and N70.11 Chronic salpingitis associated with enzyme deficiency oophoritis N70.12 Chronic oophoritis E25.8 Other adrenogenital disorders N70.13 Chronic salpingitis and oophoritis E25.9 Adrenogenital disorder, unspecified 614.2 Salpingitis and oophoritis not N70.91 Salpingitis, unspecified 256.0 Hyperestrogenism E28.0 Estrogen excess specified as acute, subacute, N70.92 Oophoritis, unspecified or chronic N70.93 Salpingitis and oophoritis, 256.1 Other ovarian hyperfunction E28.1 Androgen excess unspecified N98.1 Hyperstimulation of ovaries 614.3 Acute parametritis and pelvic N73.0 Acute parametritis and pelvic 256.2 Postablative ovarian failure E89.40 Asymptomatic postprocedural cellulitis cellulitis ovarian failure E89.41 Symptomatic postprocedural ovarian 614.4 Chronic or unspecified N73.1 Chronic parametritis and pelvic failure parametritis and pelvic
Recommended publications
  • LCD for Diagnostic Pap Smear (L22842)
    LCD for Diagnostic Pap Smear (L22842) All ICD-9 Codes (diagnosis codes) must be carried to their highest level of specification. ICD-9 Codes that Support Medical Necessity 054.10 GENITAL HERPES UNSPECIFIED 054.11 HERPETIC VULVOVAGINITIS 054.12 HERPETIC ULCERATION OF VULVA 078.0 MOLLUSCUM CONTAGIOSUM 078.10 VIRAL WARTS UNSPECIFIED 078.11 CONDYLOMA ACUMINATUM 078.19 OTHER SPECIFIED VIRAL WARTS 090.0 - EARLY CONGENITAL SYPHILIS SYMPTOMATIC - VENEREAL DISEASE 099.9 UNSPECIFIED 112.1 CANDIDIASIS OF VULVA AND VAGINA 112.2 CANDIDIASIS OF OTHER UROGENITAL SITES 171.6 MALIGNANT NEOPLASM OF CONNECTIVE AND OTHER SOFT TISSUE OF PELVIS 179 MALIGNANT NEOPLASM OF UTERUS-PART UNS 180.0 - MALIGNANT NEOPLASM OF ENDOCERVIX - MALIGNANT NEOPLASM OF 180.9 CERVIX UTERI UNSPECIFIED SITE 181 MALIGNANT NEOPLASM OF PLACENTA 182.0 - MALIGNANT NEOPLASM OF CORPUS UTERI EXCEPT ISTHMUS - 182.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF BODY OF UTERUS 183.0 - MALIGNANT NEOPLASM OF OVARY - MALIGNANT NEOPLASM OF 183.8 OTHER SPECIFIED SITES OF UTERINE ADNEXA 184.0 - MALIGNANT NEOPLASM OF VAGINA - MALIGNANT NEOPLASM OF 184.9 FEMALE GENITAL ORGAN SITE UNSPECIFIED 195.3 MALIGNANT NEOPLASM OF PELVIS 198.6 SECONDARY MALIGNANT NEOPLASM OF OVARY 198.82 SECONDARY MALIGNANT NEOPLASM OF GENITAL ORGANS 218.0 - SUBMUCOUS LEIOMYOMA OF UTERUS - LEIOMYOMA OF UTERUS 218.9 UNSPECIFIED 219.0 - BENIGN NEOPLASM OF CERVIX UTERI - BENIGN NEOPLASM OF 219.9 UTERUS PART UNSPECIFIED 220 BENIGN NEOPLASM OF OVARY 221.0 - BENIGN NEOPLASM OF FALLOPIAN TUBE AND UTERINE LIGAMENTS - 221.9 BENIGN NEOPLASM
    [Show full text]
  • Updates to ICD-10-CM Take Effect October 1, 2016
    Changes in Family Planning Coding: Updates to ICD-10-CM Take Effect October 1, 2016 Family planning providers will soon have access to new diagnosis codes, including those that better reflect the full range of contraceptive methods currently available on the market. The Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention's (CDC) National Center for Health Statistics (NCHS) reviewed the International Classification of Diseases, 10th Edition (ICD-10) for use in the US and published changes that will take effect on October 1, 2016. This set of updates are collectively known as the 2017 Addenda and are to be used for patient encounters occurring from October 1, 2016 through September 30, 2017. The 2017 Addenda includes two types of updates: 1) new codes added to ICD-10-CM and 2) edits to descriptive language of current ICD-10-CM codes that will clarify use of codes. Both updates are important for providers to understand. A new code may better represent health care services that are currently provided and should therefore be incorporated into use. A new description for a code currently in use may provide better insight into the appropriate use of codes, or may correct an error in a description that created confusion. The following pages include a list of changes to ICD-10-CM that are pertinent to family planning providers. The document is divided into three sections: 1) new ICD-10-CM codes that may be needed frequently in family planning settings; 2) new ICD-10-CM codes related to reproductive health but used infrequently in family planning settings; and 3) edits to ICD-10- CM tabular list descriptions among codes of interest to family planning providers.
    [Show full text]
  • CTRI Trial Data
    PDF of Trial CTRI Website URL - http://ctri.nic.in Clinical Trial Details (PDF Generation Date :- Thu, 30 Sep 2021 12:17:01 GMT) CTRI Number CTRI/2020/07/026410 [Registered on: 07/07/2020] - Trial Registered Prospectively Last Modified On 06/07/2020 Post Graduate Thesis Yes Type of Trial Interventional Type of Study Drug Medical Device Ayurveda Study Design Randomized, Parallel Group Trial Public Title of Study Clinical Study To Assess The Efficacy of Ayurvedic Formulations In PCOS Scientific Title of A Randomized Control Open Label Clinical Trial On The Efficacy Of Shatapushpa Churna And Study Madhutailika Basti In Nashtartava w.s.r. To Polycystic Ovarian Syndrome Secondary IDs if Any Secondary ID Identifier NIL NIL Details of Principal Details of Principal Investigator Investigator or overall Name Dr Shalvi Sharma Trial Coordinator (multi-center study) Designation M.S. Scholar Affiliation National Institute of Ayurveda, Jaipur Address Department of Prasuti Tantra evam Stri Roga National Institute of Ayurveda Madhav Villas Palace Jorawar Singh Gate Amer road Jaipur RAJASTHAN 302020 India Phone 8988071274 Fax Email [email protected] Details Contact Details Contact Person (Scientific Query) Person (Scientific Name Dr K Bharathi Query) Designation Professor and H.O.D. Affiliation National Institute of Ayurveda, Jaipur Address Department of Prasuti Tantra evam Stri Roga National Institute of Ayurveda Madhav Villas Palace Jorawar Singh Gate Amer road Jaipur RAJASTHAN 302020 India Phone 9982678508 Fax Email [email protected] Details Contact
    [Show full text]
  • Commonly Used ICD-10 Codes in Reproductive Healthcare
    FREQUENTLY USED CODES Commonly Used ICD-10 Codes in Reproductive Healthcare Female Reproductive Healthcare Breast Conditions Infertility Uterus N60.(01/02) Solitary cyst of breast (R/L) N97.0 Infertility-anovulation C54.1 Cancer of endometrium N60.(11/12) Fibrocystic change (R/L) E23.0 Hypopituarism C54.2 Cancer of myometrium N61 Mastitis, NOS N97.1 Infertility-tubal origin C54.3 Cancer of fundus uteri N64.0 Fissure and fistula of nipple N97.2 Infertility-uterine origin C54.9 Cancer of corpus uteri, unspec. N64.3 Galactorrhea N97.8 Infertility-cervical origin D25.9 Uterine myoma N64.4 Mastodynia N97.9 Female infertility, NOS N84.0 Polyp of corpus uteri N63 Lump or mass in breast N84.8 Polyp of other parts of fem genital N64.51 Induration of breast Menopause N84.9 Polyptract of fem. genital tract, unspec. N64.53 Retraction of nipple N92.4 Perimenopausal menorrhagia N85.00 Endometrial hyperplasia N64.59 Other signs/ symptoms in breast N95.0 Postmenopausal bleeding N85.4 Malposition of uterus N64.53 Retraction of nipple N95.1 Menopausal syndrome N85.6 Asherman’s syndrome O91.23 Mastitis, postpartum, unspec. N95.2 Atrophic vaginitis N85.7 Hematometra R92.8 Abnormal mammogram N95.8 Symptoms w artificial menopause N85.9 Disorder of uterus, NOS N95.9 Menopausal disorder NOS Cervix Urinary Tract C53.0 Endocervical cancer Ovary and Adnexa N30. 10 Interstitial cystitis w/o hematuria C53.1 Exocervical cancer C56.1 Malignant neoplasm of right ovary N30.11 Interstitial cystitis w/ hematuria C53.9 Cervical cancer, NOS C56.2 Malignant neoplasm of left
    [Show full text]
  • Errata to the 10/1/2016 Prioritized List
    Errata to the 10/1/2016 Prioritized List 1) On 9/13/2017 Guideline Note 144 was corrected to reference line 385 rather than line 516 in the last paragraph. The corrected text reads as follows: a. Long term proton pump inhibitor therapy is included on Line 385 for Barrett’s esophagus (ICD-10-CM K22.70). 2) On 6/29/2017, the following corrections were made: a. Website addresses were corrected for the new Oregon Health Authority Web site in all guideline notes referencing a Coverage Guidance. In addition, a web address in the Multisector Interventions section on Tobacco Use was updated. b. M67.0 (Short Achilles tendon (acquired)) was moved to line 297 NEUROLOGICAL DYSFUNCTION IN POSTURE AND MOVEMENT CAUSED BY CHRONIC CONDITIONS from line 382 DYSFUNCTION RESULTING IN LOSS OF ABILITY TO MAXIMIZE LEVEL OF INDEPENDENCE IN SELF- DIRECTED CARE CAUSED BY CHRONIC CONDITIONS THAT CAUSE NEUROLOGICAL DYSFUNCTION c. G56.23 (Lesion of ulnar nerve, bilateral upper limbs) was moved from lines 512 PERIPHERAL NERVE DISORDERS and 539 PERIPHERAL NERVE DISORDERS to line 421 PERIPHERAL NERVE ENTRAPMENT; PALMAR FASCIAL FIBROMATOSIS. d. Psoriasis corrections: i. Add psoriasis, parapsoriasis and similar ICD-10 codes to line 544 MILD PSORIASIS; DERMATOPHYTOSIS: SCALP, HAND, BODY, DEEP-SEATED 1. L40.0 Psoriasis vulgaris 2. L40.1 Generalized pustular psoriasis 3. L40.2 Acrodermatitis continua 4. L40.3 Pustulosis palmaris et plantaris 5. L40.4 Guttate psoriasis 6. L40.8 Other psoriasis 7. L40.9 Psoriasis, unspecified 8. L41.0 Pityriasis lichenoides et varioliformis acuta ii. Add psoriatic arthropathy ICD-10 codes to line 50 RHEUMATOID ARTHRITIS AND OTHER INFLAMMATORY POLYARTHROPATHIES) and remove from line SEVERE INFLAMMATORY SKIN DISEASE 1.
    [Show full text]
  • GYN Coding Changes to Note for Your Maximized Reimbursement Revised ICD-10 Gynecologic Diagnostic Codes Go Into Effect October 1
    Reimbursement ADVISER GYN coding changes to note for your maximized reimbursement Revised ICD-10 gynecologic diagnostic codes go into effect October 1. Here is a look at the added, expanded, and revised codes you will need for your practice. Melanie Witt, RN, MA n the August 2016 issue of OBG Manage- requested new codes to align with a 2009 ment, I wrote about the International joint report on the terminology for female IClassification of Diseases, Tenth Revi- pelvic floor dysfunction.1 These codes, along sion, Clinical Modification (ICD-10) coding with others, are listed in TABLE 1, page e2. changes that will occur for obstetric services, and now it is time to tackle gynecologic ser- Urinary procedure complication codes vices. The changes cover the gamut of issues Not every urogynecologist will have an issue that could not be addressed with the initial after surgery for incontinence, but if they IN THIS implementation of ICD-10, including codes do, there are tons of new and revised codes ARTICLE for contraception, prepubertal issues, post- to address every possible complication the operative complications, and urinary symp- patient may have (TABLE 2, page e3). Each of Urogynecology toms, to name a few. these codes is reported based on whether the dx codes complication is being actively treated (initial page e2 encounter: final character is A), is being fol- Urogynecology lowed up after treatment (subsequent encoun- diagnostic codes ter: final character is D), or is caused by another Gynecology Urogynecologists will find a large num- condition (sequela: final character is S). dx codes ber of changes to codes they can select on page e5 October 1, 2016.
    [Show full text]
  • Diseases of the Female Reproductive System. Part I. Methodical
    MINISTRY OF EDUCATION AND SCIENCE OF UKRAINE State Higher Educational Institution “UZHGOROD NATIONAL UNIVERSITY” MEDICAL FACULTY DEPARTMENT OF OBSTETRICS AND GYNECOLOGY Authors: As.Prof. Lemish N.Y. Ph.D, prof. Korchynska O.O. Topic: Diseases of the female reproductive system. Part I. Methodical development for practical lessons of gynecology for students of the 5th course of medical faculty Uzhhgorod - 2015 Methodical development was prepared by: N.Y. Lemish – assistant professor of the department of obstetrics and gynecology of medical faculty, Uzhgorod national university O.O. Korchynska – doctor of medical sciences, professor of department of obstetrics and gynecology, medical faculty, Uzhgorod national university Edited by: chief of the department of obstetrics and gynecology state higher educational institution “Uzhgorod national university”, doctor of medical sciences, prof. Malyar V.A. Reviewers: Y.Y. Bobik – doctor of medical sciences, professor, the head of department of maternal and neonatal care, faculty of postgraduate study, State higher educational instuitution “Uzhgorod national university” S.O.Herzanych - doctor of medical sciences, professor of department of obstetrics and gynecology, medical faculty, State higher educational institution “Uzhgorod national university” Approved by the Academic Council of the medical faculty, protocol № 7 from « 19 » march 2015 year. 2 ABBREVIATIONS MC – Menstrual cycle FSH - Follicle Stimulating Hormone AMN - Anti –Mullerian Hormone LH – Luteinizing hormone DUB – dysfunctional uterine
    [Show full text]
  • ICD-10: Clinical Concepts for OB/GYN
    Clinical Concepts ICD-10 for OB/GYN ICD-10 Clinical Concepts Series Common Codes Clinical Documentation Tips Clinical Scenarios ICD-10 Clinical Concepts for OB/GYN is a feature of Road to 10, a CMS online tool built with physician input. With Road to 10, you can: l Build an ICD-10 action plan customized for l Access quick references from CMS and your practice medical and trade associations l Use interactive case studies to see how l View in-depth webcasts for and by medical your coding selections compare with your professionals peers’ coding To get on the Road to 10 and find out more about ICD-10, visit: cms.gov/ICD10 roadto10.org ICD-10 Compliance Date: October 1, 2015 Official CMS Industry Resources for the ICD-10 Transition www.cms.gov/ICD10 1 Table Of Contents Common Codes • Abnormal Female Genital • Selected Menopausal and Cytology (Excluding other Perimenopausal Neoplasia and Malignancy Disorders Codes) • Noninflammatory Disorders • Excessive, Frequent and of Ovary, Fallopian Tubes Irregular Menstruation and Broad Ligament • General Medical and • Supervision of Normal Gynecological Examinations Pregnancy • Hypertension • Urinary Tract Infection, • Inflammation of Vagina and Cystitis Vulva • Lump in Breast and Other Disorders of Breast Primer for Clinical Documentation • Trimester • Intent of Encounter • Vomiting • Complications of Pregnancy • Abortion • Alcohol Use, Substance Abuse and Tobacco • Childbirth and Puerperium Dependence Distinct from Trimester Clinical Scenarios • Scenario 1: Abdominal Pain & Ovarian Cyst • Scenario
    [Show full text]
  • General Ultrasound
    SCHAFFER, SCHONHOLZ & DROSSMAN, LLP 488 Madison Avenue Suite 1220 New York, NY 10022 • Tel 212.755.7656 Fax 212.688.9474 PATIENT REFERRAL INFORMATION GENERAL ULTRASOUND Patient’s Name: Patient’s DOB: Patient’s Medicare#: Referring Physician’s Name & Address: Referring Physician’s Signature: Date: X CODE ABDOMINAL ULTRASOUND X CODE ABDOMINAL ULTRASOUND (cont’d) X CODE RENAL SONOGRAPHY 76700 Abdominal Ultrasound R19.01 Right upper quadrant abdominal swell, mass & lump 76770 Renal Ultrasound R10.819 Abdominal tenderness, unspec site R10.811 Right upper quadrant abdominal tenderness N30.01 Acute cystitis w/hematuria R94.5 Abnormal results of liver function studies R10.11 Right upper quadrant pain R31.1 Benign essential microscopic hematuria R10.0 Acute abdomen R10.821 Right upper quadrant rebound abdominal tenderness N20.0 Calculus of Kidney K80.18 Calculus of gallbladder w/other cholecystitis w/o obstr R10.9 Unspec abdominal pain N28.1 Cyst of kidney, acquired R10.83 Colic R10.10 Upper abdominal pain, unspec N30.91 Cystitis, unspec w/hematuria K57.93 Diverticulitis intest, part unsp w/o perf/abscess w/bld R31.0 Gross hematuria K57.92 Diverticulitis intest, part unsp w/o perf/abscess w/o bld R31.9 Hematuria Unspec K57.80 Diverticulitis intest, part unsp w/perf/abscess w/o bld X CODE PELVIC ULTRASOUND N99.521 Infection of other external stoma of urinary tract K57.32 Diverticulitis lrg intest w/o perf/abscess w/o bleed 76830 Pelvic Transvaginal Ultrasound N99.531 Infection of other stoma of urinary tract K57.81 Diverticulitis of intest, part
    [Show full text]
  • Icd-10Causeofdeath.Pdf
    A00 Cholera A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae A00.1 Cholera due to Vibrio cholerae 01, biovar el tor A00.9 Cholera, unspecified A01 Typhoid and paratyphoid fevers A01.0 Typhoid fever A01.1 Paratyphoid fever A A01.2 Paratyphoid fever B A01.3 Paratyphoid fever C A01.4 Paratyphoid fever, unspecified A02 Other salmonella infections A02.0 Salmonella gastroenteritis A02.1 Salmonella septicemia A02.2 Localized salmonella infections A02.8 Other specified salmonella infections A02.9 Salmonella infection, unspecified A03 Shigellosis A03.0 Shigellosis due to Shigella dysenteriae A03.1 Shigellosis due to Shigella flexneri A03.2 Shigellosis due to Shigella boydii A03.3 Shigellosis due to Shigella sonnei A03.8 Other shigellosis A03.9 Shigellosis, unspecified A04 Other bacterial intestinal infections A04.0 Enteropathogenic Escherichia coli infection A04.1 Enterotoxigenic Escherichia coli infection A04.2 Enteroinvasive Escherichia coli infection A04.3 Enterohemorrhagic Escherichia coli infection A04.4 Other intestinal Escherichia coli infections A04.5 Campylobacter enteritis A04.6 Enteritis due to Yersinia enterocolitica A04.7 Enterocolitis due to Clostridium difficile A04.8 Other specified bacterial intestinal infections A04.9 Bacterial intestinal infection, unspecified A05 Other bacterial food-borne intoxications A05.0 Food-borne staphylococcal intoxication A05.1 Botulism A05.2 Food-borne Clostridium perfringens [Clostridium welchii] intoxication A05.3 Food-borne Vibrio parahemolyticus intoxication A05.4 Food-borne Bacillus cereus
    [Show full text]
  • Definitions of Medicare Code Edits
    Preliminary 08/25/09 Definitions of Medicare Code Edits PBL–011 October 2009 08/25/09 Preliminary Document number PBL–011 October 2009 ii Definitions of Medicare Code Edits October 2009 Preliminary 08/25/09 About this document THE MEDICARE CODE EDITOR (MCE) detects and reports errors in the coding claims data. This manual contains a description of each coding edit with corresponding ICD-9-CM code lists. The coding edit information in this manual is effective from 10/01/2009 to 09/30/2010. October 2009 iii 08/25/09 Preliminary iv Definitions of Medicare Code Edits October 2009 Preliminary 08/25/09 Contents Preface About this document iii Chapter 1 Edit code lists 1.3 1. Invalid diagnosis or procedure code 1.4 2. E-code as principal diagnosis 1.4 3. Duplicate of PDX 1.4 4. Age conflict 1.4 5. Sex conflict 1.19 6. Manifestation code as principal diagnosis 1.38 7. Non-specific principal diagnosis 1.41 8. Questionable admission 1.41 9. Unacceptable principal diagnosis 1.42 10. Non-specific O.R. procedure 1.50 11. Non-covered procedure 1.50 12. Open biopsy check 1.53 13. Bilateral procedure 1.54 14. Invalid age 1.55 15. Invalid sex 1.55 16. Invalid discharge status 1.55 17. Limited coverage 1.56 18. Wrong procedure performed 1.57 Chapter 2 Code list changes 2.3 Changes to existing edits 2.3 New edit 2.13 Index I.1 October 2009 Contents v 08/25/09 Preliminary vi Definitions of Medicare Code Edits October 2009 Chapter 1 1Edit code lists Contents Edit code lists 1.3 1.
    [Show full text]
  • Laparoscopic Excision of Tubes and Ovaries Hs-263
    LAPAROSCOPIC EXCISION OF TUBES AND OVARIES HS-263 Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. ‘Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois, Inc. WellCare Health Plans of New Jersey, Inc. WellCare Health Insurance of Arizona, Inc. WellCare of Florida, Inc. WellCare of Connecticut, Inc. WellCare of Georgia, Inc. WellCare of Kentucky, Inc. WellCare of Louisiana, Inc. WellCare of New York, Inc. Laparoscopic Excision WellCare of South Carolina, Inc. of Tubes and Ovaries WellCare of Texas, Inc. Policy Number: HS-263 WellCare Prescription Insurance, Inc. Original Effective Date: 8/7/2014 Windsor Health Plan Windsor Rx Medicare Prescription Drug Plan Revised Date(s): 7/11/2015 APPLICATION STATEMENT The application of the Clinical Coverage Guideline is subject to the benefit determinations set forth by the Centers for Medicare and Medicaid Services (CMS) National and Local Coverage Determinations and state-specific Medicaid mandates, if any. Clinical Coverage Guideline page 1 Original Effective Date: 8/7/2014 - Revised: 7/11/2015 LAPAROSCOPIC EXCISION OF TUBES AND OVARIES HS-263 DISCLAIMER The Clinical Coverage Guideline is intended to supplement certain standard WellCare benefit plans. The terms of a member’s particular Benefit Plan, Evidence of Coverage, Certificate of Coverage, etc., may differ significantly from this Coverage Position. For example, a member’s benefit plan may contain specific exclusions related to the topic addressed in this Clinical Coverage Guideline. When a conflict exists between the two documents, the Member’s Benefit Plan always supersedes the information contained in the Clinical Coverage Guideline.
    [Show full text]